Centene Corporation (NYSE: CNC) announced December 30 that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases.
Read the full article: Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) //
Source: https://www.prnewswire.com/news-releases/centene-completes-acquisition-of-pantherx-rare-pharmacy-pantherx-301199187.html